ArticleFrontiers in oncology2025
Predictive modeling of acute radiation-induced dermatitis in nasopharyngeal carcinoma patients undergoing tomotherapy using machine learning with multimodal data integration.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- High-Recall Biomedical Language Models for Radiation Oncology Evidence Synthesis: An Integrated Systematic Review of Prediction Models for Radiotherapy-Induced Complications in Nasopharyngeal Carcinoma.Life (Basel, Switzerland) · 2026Review
- Risk factors for severe radiation-induced dermatitis in nasopharyngeal carcinoma patients undergoing radiotherapy.Frontiers in oncology · 2026Article
- AI-enabled precision prediction and proactive management of cutaneous toxicities in cancer immunoradiotherapy (ICI+RT).Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Radiation dermatitis (RD) is a common and debilitating side effect of radiotherapy in nasopharyngeal carcinoma (NPC) patients. Traditional predictive models lack sufficient accuracy for assessing acute radiation dermatitis (ARD) after tomotherapy treatment. This study aims to integrate clinical, dosimetric, and radiomic features to enhance the accuracy and robustness of predictions, thereby promoting a more personalized risk assessment for NPC patients undergoing tomotherapy. Methods: A cohort of 161 NPC patients who underwent Tomotherapy was retrospectively analyzed. Clinical, dosimetric, and radiomic features were extracted for the purpose of model development. Feature selection was conducted using statistical tests and Least Absolute Shrinkage and Selection Operator(LASSO) regression. Several machine learning algorithms were then employed to construct the predictive models, including Logistic Regression, Support Vector Machine (SVM), K-Nearest Neighbors (KNN), Random Forest, Extra Trees, XGBoost, Light Gradient Boosting Machine (LightGBM), and Multilayer Perceptron (MLP). These models were built based on clinical, radiomic, dosiomic, and combined feature sets. Model performance was assessed by evaluating the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity. To ensure fairness in comparisons, five-fold cross-validation was applied during the training of all models in the training cohort. Results: The combined model, integrating clinical, radiomic, and dosiomic features, demonstrated the highest predictive accuracy, achieving an AUC of 0.916 (95% CI: 0.866-0.967) in the training cohort and 0.797 (95% CI: 0.616-0.978) in the validation cohort. In comparison, the clinical model (AUC=0.704), radiomic model (AUC=0.865), and dosiomic model (AUC=0.640) had lower predictive performance. SVM method demonstrated superior overall performance across various model constructions. The combined model based on the SVM method exhibited optimal predictive performance, achieving the best results in both the test and validation cohorts. Conclusions: The developed combined prediction system achieves superior performance in anticipating severe ARD in NPC undergoing tomotherapy cases. This tool facilitates pre-therapeutic risk stratification, dosimetric parameter refinement, and evidence-based scheduling of preventive skin management protocols, offering a paradigm-shifting approach to individualized cutaneous protection strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.